Albumin binding raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2026-01-22. Anything still debated is marked as such rather than presented as settled.
Two principal forms appear in the literature and in research supply. One carries a drug affinity complex, a maleimide-based group that forms a covalent bond with circulating albumin. This linkage slows clearance and produces a long-lasting elevation of peptide levels. The other form lacks that group and is often labeled MOD GRF(1-29). It has a much shorter circulation time. Both variants retain the same core receptor-binding sequence. Reported half-lives differ substantially between the two.
At the pituitary, the peptide binds the growth hormone-releasing hormone receptor on somatotroph cells. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone. Somatostatin and other hypothalamic signals modulate this response. Negative feedback from insulin-like growth factor 1 also influences output. The same regulatory architecture operates with the native hormone. Whether the synthetic analog alters feedback dynamics over repeated exposure remains an open question. Most published receptor work uses cell models rather than intact human systems.
CJC-1295 is a synthetic peptide belonging to the growth hormone-releasing hormone analog family. It comprises twenty-nine amino acid residues derived from the N-terminal region of natural GHRH. The molecule incorporates several non-natural substitutions that increase resistance to enzymatic degradation. These modifications extend its activity compared with the native hormone fragment. Researchers use it to study pituitary growth hormone secretion in laboratory and clinical settings. This compound is distinct from native GHRH in its stability profile.
The second form adds a maleimide-bearing linker to the lysine at the carboxyl end. This group reacts with cysteine-34 on circulating serum albumin, forming a covalent bond that keeps the peptide in the bloodstream for far longer. ConjuChem developed the molecule as a way to extend the action of a peptide without frequent administration. The albumin attachment is the defining structural feature of the drug affinity complex version. Whether continuous exposure produces effects distinct from shorter pulses remains an unresolved research question.
| Property | Value | Notes |
|---|---|---|
| Molecular weight, DAC form | About 3647 Da | Varies with salt form |
| Molecular weight, non-DAC form | About 3358 Da | MOD GRF(1-29) |
| Solubility class | Water soluble | Also dissolves in polar solvents |
| Reported half-life, DAC form | About five to eight days | Values from human studies |
| Common synonyms | CJC-1295; MOD GRF(1-29) | Name depends on variant |
Enzymatic protection is a separate mechanism from plasma protein binding. The four substitutions in the backbone reduce recognition by dipeptidyl peptidase IV, which normally cleaves the natural hormone within minutes. Without the reactive group, this resistance still yields only a short window of activity, generally reported in the range of tens of minutes. With it, reported half-lives in early human work extended to several days. The size of that gap is the main practical distinction between the two materials.
Both forms act at the pituitary receptor for growth hormone-releasing hormone and increase growth hormone output, which in turn raises insulin-like growth factor 1. A long-acting analog produces sustained rather than pulsatile stimulation, and the physiological consequences of that pattern are not fully settled. Published human data on the extended form remain limited, and much of what circulates in discussion traces to early company reports rather than independent replication. How sustained exposure affects normal feedback remains an open question.
Lyophilised powder is the usual supplied form. The material is hygroscopic, so vials are typically equilibrated to room temperature before opening in order to prevent condensation on the contents. Long-term storage is generally described at minus twenty degrees Celsius or colder, protected from light and moisture. Repeated freeze-thaw cycles are avoided because they promote aggregation and loss of soluble material. A reconstituted solution is considerably less stable than the dry powder and is normally kept refrigerated for short periods only.
Identity and purity are assessed mainly by reversed-phase high-performance liquid chromatography combined with mass spectrometry. The chromatographic separation resolves the target peptide from truncation products and from species carrying oxidised residues, while mass measurement confirms the expected molecular mass. Because the two common variants differ by roughly 280 daltons, a mass determination distinguishes them unambiguously. Purity is often quoted as a percentage of total peak area, although that figure depends on the detection wavelength and the integration method applied.
Once in circulation, the peptide binds the growth hormone-releasing hormone receptor displayed on pituitary somatotroph cells. Receptor activation couples to Gs proteins, elevates intracellular cyclic AMP, and drives protein kinase A signaling inside the cell. That cascade increases discharge of growth hormone into the bloodstream. The analog therefore operates through a receptor pathway that already exists for the body's own releasing hormone, rather than through an engineered artificial target.
Clearance profiles diverge sharply between the two versions. The albumin-binding molecule stays in plasma for several days, whereas the unmodified analog is largely gone within about half an hour in reported work. Cleavage by dipeptidyl peptidase IV is a major contributor to the short life of the unmodified sequence. These gaps mean the two versions cannot be substituted for each other in study design or in reading results side by side.
Reports on this compound commonly follow serum growth hormone and insulin-like growth factor 1 across defined time windows. Protocols differ in sampling frequency, assay platform, and participant characteristics, which makes direct comparison between publications difficult. Some work focuses on pulsatile release patterns instead of average concentrations. Whether repeated exposure alters endogenous hormone rhythms over long periods remains an open question, and the formal literature is thinner than the volume of informal commentary implies.
When one German soldier was shot and one seriously wounded in Pancevo, Wehrmacht soldiers and the Waffen SS rounded up about 100 civilians at random...the town commander, Lt. Col. Fritz Bandelow conducted the Courts Martial...The presiding judge, SS-Sturmbannführer Rudolf Hoffmann sentenced 36 of those arrested to death. On April 21, 1941, four of the civilians were the first to be shot...On the following day, eighteen victims were hanged in a cemetery and fourteen more were shot at the cemetery wall by an execution squad of the Wehrmacht's Großdeutschland regiment. Part of the photographic presentation for the book includes a photo in which the Großdeutschland cuff title on an officer is clearly visible. Großdeutschland's complicity in many subsequent war crimes in Russia and Ukraine was a subject of the book by Omer Bartov The Eastern Front, 1941–45, German Troops, and the Barbarization of Warfare (1986, ISBN 0-312-22486-9). Under existing international law at the time, reprisals were permitted, though the Allied nations and Nazi Germany had differing interpretations of the law. In postwar war crimes trials, reprisal killings were deemed to be illegal, a conclusion enshrined in international law by the United Nations.
CendR (C-end Rule) is a position-dependent protein motif that regulates cellular uptake and vascular permeability through interaction with neuropilin-1. The CendR motif has a consensus (R/K)XX(R/K) and it is able to interact with its receptor only when the second basic residue is exposed at the C-terminus.
=== Regulation of supraoptic neurons === Vasopressin (antidiuretic hormone, ADH) is released in response to solute concentration in the blood, decreased blood volume, or blood pressure. Some other inputs come from the brainstem, including from some of the noradrenergic neurons of the nucleus of the solitary tract and the ventrolateral medulla. However, many of the direct inputs to the supraoptic nucleus come from neurons just outside the nucleus (the "perinuclear zone"). Of the afferent inputs to the supraoptic nucleus, most contain either the inhibitory neurotransmitter GABA or the excitatory neurotransmitter glutamate, but these transmitters often co-exist with various peptides. Other afferent neurotransmitters include noradrenaline (from the brainstem), dopamine, serotonin, and acetylcholine.
Note: In 2008, WOSM's conference decided that, starting at the conference in 2011, elected committee members will serve for only three years but be eligible for re-election for one additional term. Due to the COVID-19 pandemic, WOSM's conference was rescheduled from Aug 2020 to Aug 2021.
== External links == "Amylase, Alpha", I.U.B.: 3.2.1.11,4-α-D-Glucan glucanohydrolase. "Amylase, Alpha", I.U.B.: 3.2.1.11,4-α-D-Glucan glucanohydrolase. Beta-amylase at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
Sources: en.wikipedia.org
== SARS-CoV-2 proofreading enzyme == Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the COVID-19 pandemic. The SARS-CoV-2 RNA virus genome encodes a replication-and transcription complex, a multisubunit protein machine that carries out viral genome replication and transcription, processes essential to the virus life cycle. One of the proteins specified by the coronavirus genome is a non-structural protein, nsp14, that is a 3'-to-5' exoribonuclease (ExoN). This protein resides in the protein complex nsp10-nsp14 that enhances replication fidelity by proofreading RNA synthesis, an activity critical for the virus life cycle. Furthermore, the coronavirus proofreading exoribonuclease nsp14-ExoN is required for maintaining genetic recombination generated during infection.
Adults typically range from 120 to 188 cm (47 to 74 in) in head-and-body length, and 63 to 103.5 cm (24.8 to 40.7 in) in shoulder height. Although the American black bear is the smallest bear species in North America (smaller than the brown and polar bears), large males exceed the size of other bear species in other continents. Weight tends to vary according to age, sex, health and season. Adult males typically weigh between 60–300 kg (130–660 lb) with females averaging between 33% and 50% less at 40–150 kg (88–331 lb). Seasonal variation in weight is very pronounced: in autumn, their pre-den weight tends to be 30% higher than in spring, when black bears emerge from their dens. Bears on the East Coast tend to be heavier on average than their West Coast counterparts, although they typically follow Bergmann's rule regarding average size being inversely correlated with environment temperature, and bears from the northwest are often slightly heavier than the bears from the southeast. In California, studies indicate that the average adult mass is 86 kg (190 lb) in males and 58 kg (128 lb) in females. Adults in Yukon Flats National Wildlife Refuge in east-central Alaska were found to average 87.3 kg (192 lb) in males and 63.4 kg (140 lb) in females, whereas on Kuiu Island in southeastern Alaska (where nutrient dense salmon are readily available) adults averaged 115 kg (254 lb). In Great Smoky Mountains National Park, adult males averaged 112 kg (247 lb) and adult females averaged 47 kg (104 lb) per one study.
== History == 1930s – first reports of the use of sucrose for gel electrophoresis; moving-boundary electrophoresis (Tiselius) 1950 – introduction of "zone electrophoresis" (Tiselius); paper electrophoresis 1955 – introduction of starch gels, mediocre separation (Smithies) 1959 – introduction of polyacrylamide gels; discontinuous electrophoresis (Ornstein and Davis); accurate control of parameters such as pore size and stability (Raymond and Weintraub) 1965 – introduction of free-flow electrophoresis (Hannig) 1966 – first use of agar gels 1969 – introduction of denaturing agents especially SDS separation of protein subunit (Weber and Osborn) 1970 – Lämmli separated 28 components of T4 phage using a stacking gel and SDS 1972 – agarose gels with ethidium bromide stain 1975 – 2-dimensional gels (O'Farrell); isoelectric focusing, then SDS gel electrophoresis 1977 – DNA sequencing gels (Sanger) 1981 – introduction of capillary electrophoresis (Jorgenson and Lukacs) 1984 – pulsed-field gel electrophoresis enables separation of large DNA molecules (Schwartz and Cantor) 2004 – introduction of a standardized polymerization time for acrylamide solutions to optimize gel properties with preparative native PAGE A 1959 book on electrophoresis by Milan Bier cites references from the 1800s. However, Oliver Smithies made significant contributions. Bier states: "The method of Smithies ... is finding wide application because of its unique separatory power." Taken in context, Bier clearly implies that Smithies' method is an improvement.
== Distribution coefficient and log D == The distribution coefficient, log D, is the ratio of the sum of the concentrations of all forms of the compound (ionized plus un-ionized) in each of the two phases, one essentially always aqueous; as such, it depends on the pH of the aqueous phase, and log D = log P for non-ionizable compounds at any pH. For measurements of distribution coefficients, the pH of the aqueous phase is buffered to a specific value such that the pH is not significantly perturbed by the introduction of the compound. The value of each log D is then determined as the logarithm of a ratio—of the sum of the experimentally measured concentrations of the solute's various forms in one solvent, to the sum of such concentrations of its forms in the other solvent; it can be expressed as
Sources: en.wikipedia.org
It is a synthetic peptide modeled on growth hormone-releasing hormone. The molecule is used in research on pituitary growth hormone secretion. It differs from the natural hormone through several stabilizing substitutions.
The DAC form carries a maleimide group that binds albumin and extends circulation time. The non-DAC form lacks this group and clears much faster. Both share the same receptor-binding core.
It targets the growth hormone-releasing hormone receptor on pituitary somatotroph cells. Activation raises cyclic AMP and promotes growth hormone release. Normal feedback pathways remain part of the response.
A maleimide moiety reacts with the thiol of cysteine-34, forming a covalent bond. The reaction occurs in circulation without enzymatic catalysis.